Mrs Kristine Renee Maggi, PA-C in Alliance, NE - Medicare

Mrs Kristine Renee Maggi, PA-C is a medicare enrolled "Physician Assistant" physician in Alliance, Nebraska. Her current practice location is 2091 Box Butte Ave Ste 700, Alliance, Nebraska. You can reach out to her office (for appointments etc.) via phone at (308) 762-7244.

Mrs Kristine Renee Maggi is licensed to practice in Nebraska (license number 2412) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1952411647.

Contact Information

	Mrs Kristine Renee Maggi, PA-C
	2091 Box Butte Ave Ste 700, Alliance, NE 69301-4458
	(308) 762-7244
	(308) 761-1249

Physician's Profile

Full Name	Mrs Kristine Renee Maggi
Gender	Female
Speciality
Experience	Years
Location	2091 Box Butte Ave Ste 700, Alliance, Nebraska
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Mrs Kristine Renee Maggi attended and graduated from in

NPI Data:

NPI Number: 1952411647
Provider Enumeration Date: 08/30/2006
Last Update Date: 01/26/2022

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Mrs Kristine Renee Maggi such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1952411647	NPI	-	NPPES
311835	Other	WY	BLUE CROSS
970029372	Other		RAILROAD MEDICARE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RG0100X	Internal Medicine - Gastroenterology	290 (Wyoming)	Secondary
363A00000X	Physician Assistant	2412 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Kristine Renee Maggi is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Kristine Renee Maggi, PA-C 760 W 57th St, Casper, WY 82601-6445 Ph: (307) 871-9300	Mrs Kristine Renee Maggi, PA-C 2091 Box Butte Ave Ste 700, Alliance, NE 69301-4458 Ph: (308) 762-7244

News Archive

Children with biliary atresia better tolerate maternal liver grafts

Children with a rare, life-threatening disease that is the most common cause of neonatal liver failure - biliary atresia - better tolerate liver transplants from their mothers than from their fathers, according to a UCSF-led study.

FDA grants marketing clearance for Cambridge Heart's MTWA OEM module

Cambridge Heart, Inc., today announced that it has received clearance from the U.S. Food and Drug Administration to begin marketing its Microvolt T-Wave Alternans (MTWA) OEM module. The MTWA OEM module is designed to work with existing cardiac stress test platforms distributed by other manufacturers. This FDA 510(k) clearance allows Cambridge Heart to begin marketing the MTWA OEM module integrated with the Q-Stress line of stress systems manufactured by Cardiac Science Corporation, Inc..

Fred Hutchinson Cancer Research Center receives 60 research grants totaling nearly $40.4 million

Scientists at Fred Hutchinson Cancer Research Center have been awarded 60 research grants totaling nearly $40.4 million under the American Recovery & Reinvestment Act of 2009. The totals reflect data available as of Oct. 1 and reported by the National Institutes of Health.

DARA BioSciences to raise $1.4 million in registered direct offering

DARA BioSciences, Inc., a development-stage pharmaceutical company, today announced that it has entered into a definitive agreement with several institutional investors to sell 612,667 units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $1.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.

IGF-IR plays role in proliferation and motility of pancreatic cancer cell lines: Research

Insulin-like growth factor-I is upregulated in human pancreatic cancer tissues but is not expressed in surrounding non-cancerous tissues. Serum level of IGF-I is elevated in pancreatic cancer patients. Histological analysis has shown that IGF-I receptor is positive in the membrane of pancreatic cancer tissues.

Mrs Kristine Renee Maggi, PA-C - Medicare in Alliance, NE